Regulators in Kenya certify safety of GMO disease-resistant cassava

Print Friendly, PDF & Email
Nicksonn Muturi cassava

After a decade of toil, Kenyan researchers have developed a disease resistant cassava tipped to raise food security and create wealth for rural families.

The researchers are hoping for a smooth sail against regulatory hurdles that have slowed the roll out of other Genetically Modified (GMO) crops such as cotton and maize. The National Biosafety Authority (NBA) has certified the safety of the new variety that is resistant to the cassava brown streak disease (CBSD). It is also nutritionally enhanced.

This is after the Kenya Agricultural and Livestock Research Organisation (Kalro) made an application to NBA seeking environmental release (open field cultivation) that would allow farmers to grow it. NBA has now invited public comments after which national performance trials for the variety can start.

Related article:  Opinion | Putin’s 'sock puppets': How Russia 'uses' anti-GMO activists to undermine crop biotech and science

Kenya imposed a GMO ban in 2012 following a controversial study that alleged GMOs cause cancer. Since [2019], the Cabinet has been expected to give a verdict on whether to lift the ban. Instead, the government has adopted a case-by-case policy with focus recently being put on BT cotton and now cassava.

Improved awareness

Lead scientist Douglas Miano, who is in charge of developing the tuber under Virus Resistant Cassava for Africa (VIRCA plus project), told Financial Standard that awareness of GMO crops has improved. “Cotton and maize have created a lot of awareness and the discussions have advanced. For this reason, we expect things will be different.”

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists